John Renger

Insider Reports History

Location
New York, NY
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Renger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Chief Scientific Officer Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Scientific Officer Restricted Stock Units 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Scientific Officer Stock Option (Right to Buy) 0 01 Aug 2024 Direct

Insider Reports Filed by John Renger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CERE Cerevel Therapeutics Holdings, Inc. 01 Aug 2024 4 $0 4 Chief Scientific Officer 05 Aug 2024, 16:30
CERE Cerevel Therapeutics Holdings, Inc. 06 Feb 2024 3 -$89.8K 4 Chief Scientific Officer 08 Feb 2024, 19:19
CERE Cerevel Therapeutics Holdings, Inc. 19 Jan 2024 1 $0 4 Chief Scientific Officer 23 Jan 2024, 17:50
CERE Cerevel Therapeutics Holdings, Inc. 06 Feb 2023 2 $0 4 Chief Scientific Officer 08 Feb 2023, 19:34
CERE Cerevel Therapeutics Holdings, Inc. 01 Nov 2022 5 -$561K 4 Chief Scientific Officer 03 Nov 2022, 16:28
CERE Cerevel Therapeutics Holdings, Inc. 04 Oct 2022 5 -$561K 4 Chief Scientific Officer 06 Oct 2022, 16:59
CERE Cerevel Therapeutics Holdings, Inc. 10 Aug 2022 6 -$1.86M 4 Chief Scientific Officer 12 Aug 2022, 16:15
CERE Cerevel Therapeutics Holdings, Inc. 05 Aug 2022 6 -$923K 4 Chief Scientific Officer 09 Aug 2022, 21:23
CERE Cerevel Therapeutics Holdings, Inc. 20 Jul 2022 3 -$663K 4 Chief Scientific Officer 22 Jul 2022, 16:15
CERE Cerevel Therapeutics Holdings, Inc. 05 Jul 2022 6 -$695K 4 Chief Scientific Officer 07 Jul 2022, 16:06
CERE Cerevel Therapeutics Holdings, Inc. 13 Apr 2022 3 -$1.4M 4 Chief Scientific Officer 15 Apr 2022, 16:19
CERE Cerevel Therapeutics Holdings, Inc. 29 Mar 2022 3 -$315K 4 Chief Scientific Officer 31 Mar 2022, 16:05
CERE Cerevel Therapeutics Holdings, Inc. 16 Mar 2022 6 -$1.24M 4 Chief Scientific Officer 18 Mar 2022, 19:56
CERE Cerevel Therapeutics Holdings, Inc. 09 Mar 2022 4 -$895K 4 Chief Scientific Officer 11 Mar 2022, 15:08
CERE Cerevel Therapeutics Holdings, Inc. 02 Mar 2022 3 -$663K 4 Chief Scientific Officer 04 Mar 2022, 15:12
CERE Cerevel Therapeutics Holdings, Inc. 09 Feb 2022 4 -$663K 4 Chief Scientific Officer 11 Feb 2022, 17:46
CERE Cerevel Therapeutics Holdings, Inc. 23 Dec 2021 6 -$315K 4 Chief Scientific Officer 28 Dec 2021, 15:31
CERE Cerevel Therapeutics Holdings, Inc. 21 Dec 2021 3 -$212K 4 Chief Scientific Officer 23 Dec 2021, 16:14
CERE Cerevel Therapeutics Holdings, Inc. 15 Dec 2021 9 -$1.03M 4 Chief Scientific Officer 17 Dec 2021, 19:27
CERE Cerevel Therapeutics Holdings, Inc. 10 Nov 2021 7 -$2M 4 Chief Scientific Officer 15 Nov 2021, 15:18